Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeevan Scientific TechnologyBOM:538837 -0.84%65 Return-on-Tangible-Equity is 9.91% as of Mar. 2026, which is 539% above its 10-year median of 1.55. GuruFocus rates BOM:538837 with a GF Score™ of 65/100 and a GF Value™ of ₹61.81 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,199 Biotechnology companies, Jeevan Scientific Technology ranks better than 76.9% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Jeevan Scientific Technology's annualized net income for the quarter that ended in Mar. 2026 was ₹64.3 Mil. Jeevan Scientific Technology's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹648.8 Mil. Therefore, Jeevan Scientific Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 9.91%.
The historical rank and industry rank for Jeevan Scientific Technology's Return-on-Tangible-Equity or its related term are showing as below:
BOM:538837'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -58.73 Med: 1.55 Max: 69.16
Current: -0.32
During the past 13 years, Jeevan Scientific Technology's highest Return-on-Tangible-Equity was 69.16%. The lowest was -58.73%. And the median was 1.55%.
BOM:538837's Return-on-Tangible-Equity is ranked better than 76.9% of 1199
companies
in the Biotechnology industry
Industry Median: -42.21
vs BOM:538837: -0.32
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Jeevan Scientific Technology Return-on-Tangible-Equity Related Terms
Jeevan Scientific Technology Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:538837 vs VRTX, REGN, RVMD: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Jeevan Scientific Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeevan Scientific Technology Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jeevan Scientific Technology's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Jeevan Scientific Technology's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.91% mean?
Jeevan Scientific Technology (BOM:538837) has a Return-on-Tangible-Equity of 9.91% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jeevan Scientific Technology and its competitors. This is 539% above median its historical median of 1.55. According to the industry distribution chart, Jeevan Scientific Technology ranks #277 out of 1199 companies in the Biotechnology industry, placing it in the top 23.1%.
Is Jeevan Scientific Technology's Return-on-Tangible-Equity too high?
Jeevan Scientific Technology's current Return-on-Tangible-Equity of 9.91% is 539% above median its 10-year median of 1.55. Based on the distribution chart, Jeevan Scientific Technology ranks #277 out of 1199 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jeevan Scientific Technology has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Return-on-Tangible-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jeevan Scientific Technology ranks #277 out of 1199 companies for Return-on-Tangible-Equity. This places Jeevan Scientific Technology in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jeevan Scientific Technology and its competitors. Jeevan Scientific Technology's current Return-on-Tangible-Equity is 9.91%, which is 539% above median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹61.81, compared to a current price of ₹71.91 — trading 16.3% above its estimated fair value. The current Return-on-Tangible-Equity is 9.91%, which is 539% above median its 10-year median of 1.55. Jeevan Scientific Technology's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Return-on-Tangible-Equity is 9.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?
Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be overvalued.
The current stock price of ₹71.91 is trading 16.3% above its estimated GF Value™ of ₹61.81.
GuruFocus considers Jeevan Scientific Technology to be Modestly Overvalued.
Key valuation signals for BOM:538837:
Return-on-Tangible-Equity: 9.91% (539% above median its 10-year median of 1.55)
GF Value™: ₹61.81 vs. price of ₹71.91 (16.3% above fair value)
No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
65GF Score
Get the complete analysis for BOM:538837
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538837 has been successfully added to your 
